| Code | Description | Claims | Beneficiaries | Total Paid |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,628 |
5,204 |
$333K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
502 |
447 |
$87K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,317 |
578 |
$43K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,283 |
3,438 |
$14K |
| 87640 |
|
580 |
523 |
$5K |
| 87486 |
|
527 |
477 |
$4K |
| 87631 |
|
35 |
35 |
$3K |
| 87500 |
|
218 |
209 |
$1K |
| 87581 |
|
328 |
291 |
$1K |
| 87481 |
|
405 |
152 |
$802.89 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
120 |
105 |
$137.52 |
| 87541 |
|
46 |
43 |
$69.48 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
65 |
59 |
$61.77 |
| 87641 |
|
25 |
23 |
$0.00 |